Effective as of May 4, 2023, the Board of Directors (the Board) of Talis Biomedical Corporation (the Company) appointed Ms. Kimberly Popovits, who has served as a member of the Board since March 2020, as Lead Independent Director of the Board in accordance with the Company's Amended and Restated Bylaws.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.3 USD | +0.43% | +1.64% | +24.83% |
May. 08 | Talis Biomedical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 02 | North American Morning Briefing : Stocks Seen -2- | DJ |
1st Jan change | Capi. | |
---|---|---|
+24.83% | 16.94M | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- TLIS Stock
- News Talis Biomedical Corporation
- Talis Biomedical Corporation Appoints Kimberly Popovits as Lead Independent Director